Avenu Medical, now part of Medtronic, is a leading medical company based in San Juan Capistrano, CA, specializing in the development and distribution of innovative vascular access systems. Their flagship product, the Ellipsys Vascular Access System, has gained FDA approval and European CE Mark approval for creating arteriovenous fistulas in patients with chronic kidney disease requiring hemodialysis. With its patented tissue fusion technology and a track record of over 2000 successful procedures, Ellipsys offers a minimally invasive and highly effective solution for patients seeking a permanent AV fistula.
Avenu Medical's Ellipsys Vascular Access System is revolutionizing AV fistula creation by providing a groundbreaking alternative to traditional methods that have remained unchanged for the past 50 years. This minimally invasive procedure, guided by ultrasound imaging, eliminates the need for surgery, implants, and vessel suturing, resulting in a scar-free and aesthetically pleasing outcome. With a growing patient population and a global demand for hemodialysis, Avenu Medical's Ellipsys Vascular Access System is poised to make a significant impact in improving the quality of life for millions of patients worldwide.
Generated from the website